Gold edged higher on Friday but remained on track for a weekly decline of about 2.1 percent, as investors weighed persistent inflation concerns against a firmer US interest-rate outlook. Rising Treasury yields and expectations that the Federal Reserve may keep policy restrictive have reduced the metal’s appeal as a non-yielding safe haven.
"Rate-Hike Bets Cap Gold's Rebound as Weekly Loss Looms"
Gold edged higher on Friday but remained on track for a weekly decline of about 2.1 percent, as investors weighed persistent inflation concerns against a firmer US interest-rate outlook. Rising Treasury yields and expectations that the Federal Reserve may keep policy restrictive have reduced the metal’s appeal as a non-yielding safe haven.
Rate-Hike Bets Cap Gold's Rebound as Weekly Loss Looms
RDU Global Wire
Macro Economy & Fiscal Policy Desk
Gold edged higher on Friday but remained on track for a weekly decline of about 2.1 percent, as investors weighed persistent inflation concerns against a firmer US interest-rate outlook. Rising Treasury yields and expectations that the Federal Reserve may keep policy restrictive have reduced the metal’s appeal as a non-yielding safe haven.
Editorial & Verification Notice
Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.
Related Coverage
U.S. Has Floated NATO Membership for Ukraine in Recent Talks, Deepening Diplomatic Stakes
The United States has raised the possibility of NATO membership for Ukraine in recent meetings, according to a Wall Street Journal report, in a sign that Washington is exploring new security frameworks as the war grinds on. The idea has already drawn sharp resistance from Moscow, while President Volodymyr Zelenskyy is pressing for clarity on what an Article 5-style guarantee would actually mean in practice.
U.S. Alarm Grows Over China’s Grip on Drug Supply Chains
Washington is confronting fresh warnings that China’s expanding role in early-stage drug development and pharmaceutical supply chains could give Beijing outsized leverage over the global biopharma industry. The concern, highlighted in recent reporting and a U.S. panel warning, is not that China already dominates finished medicines, but that it is steadily building control over the upstream inputs and innovation pipeline that underpin future drug production.
Delaware Regulator Says It Was Misled in Probe of Mark Walter’s Insurance Assets
Delaware’s insurance regulator has said it was intentionally misled during its review of insurance assets linked to billionaire investor Mark Walter, intensifying scrutiny of a complex web of affiliated holdings. The dispute underscores how fragmented state oversight can leave regulators struggling to assess the true financial condition of large insurance groups with cross-ownership ties.
